TOMI (TOMZ) Q1 2026 Revenue Up 5% Year-Over-Year with Backlog Growth
Published on · Source: finance.yahoo.com

AI Summary
Summarized by AI from the source belowIn Q1 2026, TOMI (TOMZ) reported a 5% year-over-year revenue increase and a significant 67% sequential revenue jump from Q4 2025. Notably, applicator sales grew by 139% year-over-year, exceeding total sales for 2025. The company also achieved a $296,000 positive operating cash flow, a $572,000 improvement year-over-year, while operating expenses decreased by 15%. TOMI's backlog expanded to $2.2 million, up by $0.5 million from the end of 2025, highlighting strong demand in their integrated system and service offerings.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Related News

DB Growth Momentum Targets for 2028 Gain Traction
Sep 25

Abeona Therapeutics stock Buy rating maintained by H.C. Wainwright
Sep 25

Ultragenyx Stock Rating Reiterated by H.C. Wainwright on FDA Approval
Sep 25

Surrozen Stock Target Raised on Wnt Pathway Validation Insight
Sep 25